YHYu-Hsiang Hung

Yu-Hsiang Hung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yu-Hsiang Hung has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chuan-Teng Liu

    Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan

    1 shared publication
  • Dennis A Brown

    Manchester University College of Pharmacy, Natural and Health Sciences, Fort Wayne, IN, USA

    1 shared publication
  • Hung-Rong Yen

    Research Center of Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan

    1 shared publication
  • Jui-Hung Jimmy Yen

    Department of Microbiology and Immunology, Indiana University School of Medicine, Fort Wayne, IN, USA

    1 shared publication
  • Mei-Yun Chu

    Research Center for Traditional Chinese Medicine, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan; Chinese Medicine Research Center, China Medical University, Taichung, Taiwan

    1 shared publication
  • Pa-Fan Hsiao

    School of Medicine, College of Medicine MacKay Medical University New Taipei City Taiwan

    1 shared publication

Latest Publications

  • Open Access

    Association of Secondary Primary Malignancies in Cutaneous Lymphoma: A Narrative Review

    by Yu-Hsiang Hung, Pa-Fan Hsiao

    Cutaneous lymphomas are a heterogeneous group of extranodal non-Hodgkin lymphomas with distinct clinical and biological features, broadly classified into cutaneous T-cell lymphomas (CTCL) and cutaneous B-cell lymphomas (CBCL). With improved survival due to early detection and therapeutic advances, the emergence of second primary malignancies (SPMs) has become a clinical concern. SPMs, defined as new, distinct malignant neoplasms arising synchronously or metachronously with the index cancer, can significantly impair prognosis and quality of life. In this narrative review, we meticulously examine the current literature, to synthesize evidence on SPMs’ incidence and risk factors in patients with primary cutaneous lymphomas. Evidence from population-based and institutional studies consistently demonstrates elevated risks of hematologic and solid tumors in CTCL. By contrast, data on CBCL remain limited, though recent population-based analyses suggest increased risks of certain hematologic malignancies and solid tumors. We further propose development mechanisms for SPMs, including treatment-related mutagenesis, shared genetic susceptibilities, chronic antigenic stimulation, and immune dysregulation. Lastly, we highlight the clinical implications of these findings, underscoring the need for vigilant surveillance, patient education, and tailored screening strategies. Future research should prioritize large-scale, prospective, and molecularly integrated studies to refine risk stratification and guide personalized survivorship care of this vulnerable population.

  • Open Access

    Targeting Nrf2 with 3 H-1,2-dithiole-3-thione to moderate OXPHOS-driven oxidative stress attenuates IL-17A-induced psoriasis

    by Chuan-Teng Liu, Jui-Hung Jimmy Yen, Dennis A Brown, Ying-Chyi Song, Mei-Yun Chu, Yu-Hsiang Hung, Yi-Huan Tang, Po-Yuan Wu, Hung-Rong Yen